| Primary information |
|---|
| ID | antitb_1534, |
| Name | 25613372 |
| N-Terminal modification | Proregion |
| C-Terminal Modification | SVFPQQTTGQLAELQPQDRAGARASWMPMFQRRRRR |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 36 |
| Source | L |
| Origin | Cationic |
| Species | Protein derived |
| Strain | Derived from Hepcidin protein |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | induce expression of IFN-γ |
| Combination Therapy | Cause structural damage to mycobacteria |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |